ISBT 128 implementation plan for cellular therapy products.
The publication of new standards for terminology and labeling marks an important step in ensuring consistency and traceability of cellular therapies at the global level. However, it is only with the widespread implementation of the standard that the benefits can be truly realized. This paper provides guidance on the practical aspects of adopting these new standards for organizations with differing current levels of computerization. It discusses project management, equipment, licensing, and validation topics.
Ashford
Paul
P
Distler
Pat
P
Gee
Adrian
A
Lankester
Alan
A
Larsson
Stella
S
Feller
Irene
I
Loper
Kathy
K
Pamphilon
Derwood
D
Poston
Leigh
L
Rabe
Fran
F
Slaper-Cortenbach
Ineke
I
Szczepiorkowski
Zbigniew
Z
Warkentin
Phyllis
P
D001771:Blood Banks / Q000592:standards*; D001803:Blood Transfusion / Q000592:standards; D019983:Guideline Adherence; D006801:Humans; D007391:International Cooperation; D017410:Practice Guidelines as Topic / Q000592:standards*; D011356:Product Labeling / Q000592:standards*; D011786:Quality Control; D012984:Software; D019737:Transplants / Q000592:standards*